{
  "created_at": "Mon Jun 06 14:51:41 +0000 2022",
  "id_str": "1533814738966220801",
  "full_text": "A new study of an AstraZeneca breast-cancer drug showed it cut the risk of tumor progression by half for people with the most advanced form of the disease https://t.co/JqkGB46b2g",
  "display_text_range": [
    0,
    178
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/JqkGB46b2g",
        "expanded_url": "https://on.wsj.com/395RP2W",
        "display_url": "on.wsj.com/395RP2W",
        "indices": [
          155,
          178
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 28,
  "favorite_count": 97,
  "possibly_sensitive": false,
  "original_created_at": "Mon Jun 06 14:15:05 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "アストラゼネカ社の乳がん治療薬に関する新たな研究で、最も進行した状態の乳がん患者の腫瘍の進行リスクを半減させることが示された https://t.co/JqkGB46b2g 。"
    },
    {
      "locale": "zh",
      "full_text": "一项关于阿斯利康乳腺癌药物的新研究显示，该药物可将患有该疾病最晚期的人的肿瘤进展风险降低一半https://t.co/JqkGB46b2g。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "一項關於阿斯利康乳腺癌藥物的新研究顯示，該藥物可將患有該疾病最晚期的人的腫瘤進展風險降低一半https://t.co/JqkGB46b2g。"
    }
  ]
}